End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality

Circulation

Volumn 96, Issue 1, 1997, Pages 116-121

  Migrino, Raymond Q ^a   Young, James B ^a   Ellis, Stephen G ^a   White, Harvey D ^b   Lundergan, Conor F ^c   Miller, Dave P ^a   Granger, Christopher B ^c   Ross, Allan M ^c   Califf, Robert M ^d   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac volume; Myocardial infarction; Prognosis; Remodeling; Thrombolysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DRUG USE; FEMALE; FIBRINOLYTIC THERAPY; HEART VENTRICLE REMODELING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030754005     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.116     Document Type: Article

References (38)

1. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987;30:73-110.
2. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
3. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 1994;89:61-67.
4. Lewis T. The experimental production of paroxysmal tachycardia and the effects of ligation of the coronary arteries. Heart. 1990;1:98-136.
5. Shah P, Pichler, M, Berman, D, Singh BN, Swan JC. Left ventricular ejection determined by radionuclide ventriculography in early stages of first transmural myocardial infarction and its relationship to short term mortality and morbidity. Am J Cardiol. 1980;45:542-546.
6. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
7. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
8. Dodge HT, Sandler H, Ballew DW, Lord JDJ. The use of biplane angiocardiography for the measurement of left ventricular volume in man. Am Heart J. 1960;60:762-764.
9. Harrell FEJ, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80:1198-1202.
10. Breiman L, Friedman JH. Estimating optimal transformations for multiple regressions and correlations. J Am Stat Assoc. 1985;80: 580-619.
11. Hosmer DW, Lemeshow S. A goodness-of-fit test for multiple logistic regression model. Commun Stat. 1980;A10:1043-1069.
12. Pirolo JS, Hutchins GM, Moore GW. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol. 1986;7:349-354.
13. Swan HJ. Left ventricular systolic and diastolic dysfunction in the acute phases of myocardial ischaemia and infarction, and in the later phases of recovery: function follows morphology. Eur Heart J. 1993;14:48-56.
14. Mitchell GF, Pfeffer MA. The role of geometry in left ventricular remodeling after myocardial infarction. Cardiol Rev. 1995;3:71-78.
15. Ertl G, Gaudron P, Hu K. Ventricular remodeling after myocardial infarction: experimental and clinical studies. Basic Res Cardiol. 1993;88:125-137.
16. White HD. Remodelling of the heart after myocardial infarction. Aust N Z J Med. 1992;22:601-606.
17. Kostuk WJ, Kazamias TM, Gander MP, Simon AL, Ross J Jr. Left ventricular size after myocardial infarction: serial changes and their prognostic significance. Circulation. 1973;47:1174-1179.
18. Gaudron P, Eilles C, Ertl G, Kochsiek K. Compensatory and non-compensatory left ventricular dilatation after myocardial infarction: time course and hemodynamic consequences at rest and during exercise. Am Heart J. 1992;123:377-385.
19. Nixdorff U, Erbel R, Pop T, Rupprecht HJ, Henrichs KJ, Morchen S, Meyer J. Long-term follow-up of global and regional left ventricular function by two-dimensional echocardiography after thrombolytic therapy in acute myocardial infarction. Int J Cardiol. 1993;41:31-47.
20. Christakis GT, Weisel RD, Buth KJ, Fremes SE, Rao V, Panagiotopoulos KP, Ivanov J, Goldman BS, David TE. Is body size the cause for poor outcomes of coronary artery bypass operations in women? J Thorac Cardiovasc Surg. 1995;110:1344-1356.
21. Kass DA, Maughan WL, Ciuffo A, Graves W, Healy B, Weisfeldt ML. Disproportionate epicardial dilatation after transmural infarction of the canine left ventricle: acute and chronic differences. J Am Coll Cardiol. 1988;11:177-185.
22. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
23. Marino P, Destro G, Barbieri E, Bicego D. Reperfusion of the infarct-related coronary artery prevents left ventricular expansion and beyond myocardial salvage. Am Heart J. 1992;123: 1157-1165.
24. Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol. 1987;9: 989-995.
25. Topol EJ, Califf RM, Vandormael M, Grines C, George B, Sanz ML, Wall T, O'Brien M, Schwaiger M, Young S, Popma JJ, Sigmon K, Lee KL, Ellis SG. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation. 1992;85:2090-2099.
26. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
27. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC, Aliot E, Persson S, Camm J. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333: 1670-1676.
28. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
29. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
30. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992;327:678-684.
31. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction: the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. N Engl J Med. 1995;332:80-85.
32. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
33. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation. 1995;92:3132-3137.
34. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755-763.
35. Weintraub WS, Wenger NK, Kosinski AS, Douglas JS, Liberman HA, Morris DC, King SB. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol. 1994;24:81-90.
36. Garini A, Emanuelli C, Fadin BM, Manzetti G, Distante R, Astorri E. Female gender and acute myocardial infarction: what role does it play in the early and late prognosis? Minerva Cardioangiol. 1994;42: 395-402.
37. Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med. 1992;116:785-790.
38. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Vande Werf F, Califf RM. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41 021 patients. Circulation. 1995;91:1659-1668.